Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.7 USD | -1.30% |
|
+0.28% | +56.25% |
06-26 | Monetary policy is getting even more confusing | ![]() |
06-26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.25% | 14.43B | |
+20.38% | 127B | |
+24.32% | 117B | |
+25.44% | 27.67B | |
-18.11% | 20.33B | |
-15.17% | 16.79B | |
-14.76% | 15.63B | |
+12.75% | 14.84B | |
-47.10% | 14.65B | |
+148.66% | 12.49B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Transcript : Sarepta Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 10